Akoustis Technologies, Inc. and Aktis Oncology Prepare for Their Public Debuts
Aktis OncologyAktis Oncology(US:AKTS) Financial Modeling Prep·2026-01-09 10:04

Akoustis Technologies, Inc. is gearing up for a significant milestone as it prepares to go public on the NASDAQ, with plans to offer 17.65 million shares priced between $16 and $18. This strategic move is aimed at raising substantial capital, positioning Akoustis alongside other tech sector giants. Specializing in the development of advanced RF filter solutions for the wireless industry, Akoustis is set to compete with leading firms such as Qorvo and Broadcom.Similarly, Aktis Oncology, a clinical-stage onco ...